Founded in 2010 by scientists spanning medicine, physics, biology, biochemistry and nanotechnology, ANPAC Bio-Medical Science develops multi-cancer detection and early cancer-risk screening technologies. The company’s patented Cancer Differentiation Analysis approach has been used in more than 300,000 multi-cancer test samples, supporting screening for cancer risks in the general population.
UE LifeSciences IncFounded in 2009, UE LifeSciences develops hand-held medical devices and digital tools that make early cancer detection more accessible, starting with its FDA-cleared iBreastExam for quick, painless, radiation-free breast-lump screening. Its Philadelphia-rooted, globally distributed team designs systems for community health workers and has supplied more than 2 million breast exams across 10 markets, with newer tools extending screening to cervical and oral cancer. The company also established an ISO 13485- and WHO-GMP-certified manufacturing facility in India as it expanded internationally.WEST CHESTER, PA
Ultrasonic Medical Mapping, IncBethesda-based Ultrasonic Medical Mapping develops radiation-free cancer-detection technology, adapting a mature method from defense and aerospace testing for medical use. Its patented system is focused on finding pancreatic tumors earlier and at smaller sizes than existing imaging and non-imaging technologies, and the company has built a preclinical prototype for technical validation. UMM is now working toward clinical testing with hospital and clinical partners.BETHESDA, MD
Creatv BioPrivately held Creatv MicroTech, led by MIT-trained scientist and founder Cha-Mei Tang, is known for bringing diagnostics together with microfabrication to develop cancer research technologies. Its Creatv Bio division applies that expertise to blood-based liquid-biopsy research for cancer screening and treatment monitoring, including work with biopharma companies and clinical-trial sponsors. Creatv MicroTech received an R&D 100 Award in 2006 and was named Montgomery County’s Biotech Company of the Year in 2013.POTOMAC, MD
20/20 BioLabsFounded by Jonathan Cohen, 20/20 BioLabs develops and commercializes AI-powered laboratory blood tests aimed at detecting cancer and chronic disease earlier. Its OneTest for Cancer uses a protein tumor-marker approach and can be collected at home with an upper-arm device, while the company’s longevity test measures inflammation-related biomarkers to support proactive health decisions. The company’s laboratory is CAP accredited and CLIA licensed, and its multi-cancer test has performed in blinded studies conducted by the U.S. National Cancer Institute.GAITHERSBURG, MD